Analyst Upgrades
Name |
Symbol |
Analyst |
Action |
Rating |
Closing Price |
Target Price |
STA Analyst Rating |
||||
|
Athabasca Oil Corp
|
ATH:CA | TD Securities | Upgrades | Buy | 3.36 | 4.5 | Strong Buy | ||||
|
Athabasca Oil Corp
|
ATH:CA | RBC | Upgrades | Outperform | 3.36 | 5 | Strong Buy | ||||
|
Athabasca Oil Corp
|
ATH:CA |
Desjardins Securities
|
Upgrades | Buy | 3.36 | 4.75 | Strong Buy | ||||
| Biogen Inc | BIIB |
Raymond James
|
Upgraded by | Market Perform – Outperform | 233.87 | 283 | Strong Buy | ||||
| Bioventus Inc | BVS |
Canaccord Genuity
|
Upgrades | Buy | 4.52 | 7 | Strong Buy | ||||
| Datadog Inc | DDOG | Stifel Nicolaus | Upgrades | Buy | 114.31 | 140 | Strong Buy | ||||
|
JB Hunt Transport Services Inc
|
JBHT | UBS | Upgrades | Neutral | 188.08 | 205 | Buy | ||||
| Qiagen NV | QGEN |
Goldman Sachs & Co.
|
Upgrade | Neutral – Buy | 41.44 | 50 | Strong Buy | ||||
| Q2 Holdings | QTWO | Stephens | Upgrades | Overweight | 37.16 | 46 | Buy | ||||
|
Schneider National Inc
|
SNDR |
Wells Fargo & Company
|
Upgrades | Equal-Weight | 23.67 | 25 | Buy | ||||
|
Sphere Entertainment Co.
|
SPHR |
Seaport Global Securities
|
Upgrades | Buy | 31.25 | 38 | Buy | ||||
|
VistaGen Therapeutics Inc
|
VTGN |
Jefferies & Company
|
Upgrades | Buy | 4.43 | 15 | Strong Buy |
